SEATTLE, July 10, 2013 (GLOBE NEWSWIRE) -- Attorney Advertising. Keller Rohrback L.L.P. (www.krcomplexlit.com) is currently investigating Fat Zero and Extreme Body Slim, weight loss products promoted and sold by Floyd Nutrition LLC via various channels including websites operated by Floyd Nutrition LLC and in some retail stores. The investigation focuses on the allegedly false claims made in the marketing of Fat Zero and Extreme Body Slim. On June 17, 2013, the Food and Drug Administration ("FDA") advised consumers not to purchase or use Fat Zero and Extreme Body Slim, and to throw the products away.
According to the FDA's laboratory analysis, Fat Zero and Extreme Body Slim contain sibutramine, among other ingredients. Sibutramine is a prescription diet drug that the FDA removed from the U.S. market in October 2010 for safety reasons. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some individuals and may present a significant risk to those with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. Fat Zero also contains phenolphthalein. Phenolphthalein was an ingredient in some over-the-counter laxative products until 1999 when the FDA reclassified the ingredient as "not generally recognized as safe and effective."
If you or someone you know used Fat Zero or Extreme Body Slim and would like to discuss our investigation related to the allegedly false claims about Fat Zero and Extreme Body Slim, please contact paralegal AJ de Vries or attorneys Gretchen Freeman Cappio or Michael Woerner at (800) 776-6044 or via email at firstname.lastname@example.org.
Keller Rohrback, with offices in Seattle, Phoenix, New York and Santa Barbara, has successfully pursued claims against product manufacturers and distributors on behalf of our clients. We are committed to helping those harmed by anti-consumer practices, and have achieved multi-million dollar results on behalf of classes of Plaintiffs.
Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.